
Tirzepatide Revolutionizes Sleep Apnea Treatment
Summary Tirzepatide, a drug initially developed for diabetes management, has gained FDA approval for treating obstructive sleep apnea (OSA) in adults with obesity. Clinical trials demonstrate significant reductions in sleep disruptions and weight loss with […]